このアイテムのアクセス数: 79
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
s13104-021-05864-6.pdf | 1.04 MB | Adobe PDF | 見る/開く |
タイトル: | Association between induction of the self-management system for preventing readmission and disease severity and length of readmission in patients with heart failure |
著者: | Nakane, Eisaku Kato, Takao ![]() ![]() ![]() Tanaka, Nozomi Kuriyama, Tomoari Kimura, Koki Nishiwaki, Shushi ![]() ![]() Hamaguchi, Toka Morita, Yusuke Yamaji, Yuhei Haruna, Yoshisumi Haruna, Tetsuya Inoko, Moriaki |
著者名の別形: | 加藤, 貴雄 田中, 希 |
キーワード: | Self-care management Heart failure Readmission Rehospitalization |
発行日: | 2021 |
出版者: | Springer Nature BMC |
誌名: | BMC Research Notes |
巻: | 14 |
論文番号: | 452 |
抄録: | [Objective] We recently developed the self-management system using the HF points and instructions to visit hospitals or clinics when the points exceed the pre-specified levels. We found that the self-management system decreased the hospitalization for HF with an increase in unplanned visits and early intervention in the outpatient department. However, it is unclear whether we managed severe HF outpatients who should have been hospitalized. In this study, we aimed to compare HF severity in rehospitalized patients with regard to self-management system use. [Results] We retrospectively enrolled 306 patients (153 patients each in the system user and non-user groups) using propensity scores (PS). We compared HF severity and length of readmission in rehospitalized patients in both groups. During the 1-year follow-up period, 24 system users and 43 non-system users in the PS-matched cohort were hospitalized. There were no significant differences between the groups in terms of brain natriuretic peptide levels at readmission, maximum daily intravenous furosemide dose, percentage of patients requiring intravenous inotropes, duration of hospital stay and in-hospital mortality. These results suggest that the HF severity in rehospitalized patients was not different between the two groups. |
著作権等: | © The Author(s) 2021 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. |
URI: | http://hdl.handle.net/2433/277908 |
DOI(出版社版): | 10.1186/s13104-021-05864-6 |
PubMed ID: | 34922617 |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス